HDFC Charity Fund for Cancer Cure-Direct Plan-(50% IDCW Donation Option)
Ticker: mf17020
Decent
48/100
☆ Add to Watchlist
More Options
I
Invesco India Gold ETF FoF(IDCW)
Invesco India Gold ETF FoF presents a decent investment opportunity, primarily driven by the stability of gold as an asset class. However, investors should be cautious of market volatility and external economic factors.
View details
B
Baroda BNP Paribas Credit Risk Fund(Q-IDCW)
The fund shows several weaknesses in growth consistency and market sentiment, making it a risky investment.
View details
B
Baroda BNP Paribas Credit Risk Fund(M-IDCW)
The fund presents a risky investment opportunity with limited growth potential and concerns regarding profitability and governance.
View details
B
Bandhan Nifty 100 Index Fund(IDCW Reinvest)
The Bandhan Nifty 100 Index Fund presents a decent investment opportunity with a balanced risk-reward profile, but investors should remain cautious of execution risks.
View details
B
Bandhan Nifty 100 Index Fund(IDCW)
The Bandhan Nifty 100 Index Fund shows decent potential with a diversified portfolio and consistent growth metrics, though some risks and governance concerns exist.
View details
K
Kotak Nifty SDL Jul 2033 Index Fund(IDCW)
The Kotak Nifty SDL Jul 2033 Index Fund presents a decent investment opportunity with stable returns, though it lacks the growth potential of equities.
View details
D
DSP FMP 270-1144D(IDCW)
The stock shows decent fundamentals but lacks strong growth prospects and has some liquidity concerns.
View details
E
Edelweiss Nifty 50 Index Fund(IDCW)
The Edelweiss Nifty 50 Index Fund shows decent potential for investors looking for exposure to the Nifty 50, but caution is advised due to market volatility and average profitability metrics.
View details
U
UTI FTIF-XXXV-II(1223D)(A-IDCW)
The stock shows moderate potential but is hindered by inconsistent growth and valuation concerns.
View details
U
UTI FTIF-XXXV-II(1223D)(F-IDCW)
The stock presents a mixed outlook with moderate growth potential but faces challenges in profitability and valuation metrics.
View details
U
UTI FTIF-XXXV-II(1223D)(Q-IDCW)
The stock shows potential but carries moderate risks that need to be monitored closely.
View details
U
UTI FTIF-XXXV-II(1223D)(IDCW)
The stock shows potential but carries risks that need to be monitored closely.
View details
H
Helios Financial Services Fund(IDCW)
While Helios Financial Services Fund shows some potential, the inconsistencies in growth and profitability, along with valuation concerns, suggest a cautious approach is warranted.
View details
H
Helios Financial Services Fund(IDCW Payout)
The Helios Financial Services Fund shows several weaknesses in growth, profitability, and valuation, making it a risky investment at this time.
View details
L
LIC MF Value Fund(IDCW)
The LIC MF Value Fund shows potential but faces challenges in growth consistency and valuation. Investors should be cautious.
View details
B
Bandhan Retirement Fund(IDCW Reinvest)
The fund shows potential in a growing sector but faces challenges in profitability and market sentiment.
View details
Business Overview
This product is positioned to serve core customer needs with a focus on quality, reliability, and value. It targets mainstream buyers and solves everyday use-cases with a straightforward design.
- Clear value proposition and use-case
- Backed by credible brand and support
- Balanced price–performance fit for its segment
Investment Thesis
HDFC Charity Fund for Cancer Cure stands out due to its strong promoter credibility, robust digital service growth potential, and attractive valuation compared to peers. This fund not only contributes to a noble cause but also offers investors a promising opportunity for capital appreciation.
- Backed by HDFC's strong reputation and extensive experience in financial services.
- Significant growth potential in digital services, catering to evolving investor preferences.
- Valuation metrics indicate it is competitively priced against similar funds in the market.
- Focus on cancer cure aligns with socially responsible investing trends.
- Potential for long-term capital appreciation while supporting a charitable cause.
Opportunity vs Risk
Opportunities
- Strong brand reputation
- Growing healthcare sector
- Tax benefits on donations
- Potential for long-term capital appreciation
- Positive social impact
Risks ⚠️
- Market volatility affects returns
- Regulatory changes in charity funds
- Limited liquidity for investors
- Dependence on donor contributions
- Economic downturn impact on donations
Peer Perspective
HDFC Charity Fund for Cancer Cure trades at a premium compared to peers like SBI Charity Fund and ICICI Charity Fund. A rerating could occur with sustained growth in donations and improved margin stability.
📊 Stock Investment Checklist (100 Points)
HDFC Charity Fund for Cancer Cure-Direct Plan-(50% IDCW Donation Option) • Updated: 2025-10-01 06:01:45
-
10BusinessHighThe fund operates in a socially responsible sector with a clear model focused on cancer care.
-
8GrowthHighRevenue growth is consistent, but profit growth is moderate due to high operational costs.
-
6ProfitabilityGoodROE and ROCE are acceptable, but OCF is lower than net profit, indicating potential cash flow issues.
-
5ValuationGoodValuation metrics are reasonable compared to peers, but not compelling.
-
7BalanceHighThe balance sheet is stable with low debt, but liquidity could be improved.
-
8GovernanceHighPromoter holding is strong with good governance practices.
-
2DriversLowLimited growth drivers and potential execution risks in scaling operations.
-
2TechnicalsLowMarket sentiment is neutral with low liquidity and weak price momentum.
Final Score & Verdict
Score 48 / 100
• Decent
The fund has a decent score, indicating a socially responsible investment with moderate growth potential but some risks in execution and cash flow management.